FDA Approves Sarilumab for Adults With Rheumatoid Arthritis FDA Approves Sarilumab for Adults With Rheumatoid Arthritis

The drug will be marketed in self-injectible prefilled syringes and pens to be used once every 2 weeks. It offers an alternative to drugs such as methotrexate.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news